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Abstract 
Aim  
The aim of this systematic review and meta-analysis was to evaluate the effect of 
carbohydrate restriction on glycaemic control in Type 2 DM.  
Methods 
We searched Medline, EMBASE, & CINAHL from 1976 to April 2018. We included randomised 
controlled trials (RCTs) which restricted the quantity of carbohydrate compared to a control 
diet that aimed to maintain or increase carbohydrate, reported HbA1c as an outcome 
measure and reported the amount of carbohydrate consumed during or at the end of the 
study, with outcomes reported at 3 months or longer. 
Results 
We identified 1,402 studies. Twenty-five RCTs met inclusion criteria, incorporating 2,132 
participants for the main outcome. The pooled effect estimate from meta-analysis was WMD 
-0.09% (95% CI -0.28%, 0.10%) P = 0.34, I2 80%, P <0.001 suggesting no effect from restricting 
the quantity of carbohydrate on HbA1c. Sub group analysis of diets containing 50-130g of 
carbohydrate resulted in a pooled effect estimate of -0.49% (-0.75, -0.23) P <0.001, I2 0%, P = 
0.56 suggesting a clinically and statistically significant effect on HbA1c in favour of low CHO 
diets in studies of 6 months or less in duration. 
Conclusions 
There was no overall pooled effect on HbA1c in favour of restricting carbohydrate, however 
restriction of carbohydrate to 50-130g per day has beneficial effects on HbA1c & weight in 
trials up to 6 months. Future RCTs should be >12months, assess pre-study carbohydrate 
intake, use recognised definitions of low carbohydrate diets and examine reasons for non-
concordance in greater detail.  
Source of funding: NIHR CDRF-2014-05-30. (PROSPERO: CRD42015023586) 
 
 
 
 
 
 
Novelty Statement 
 A large volume number of trials and systematic reviews in this field show conflicting 
results for the effect of restricting carbohydrate on glycaemic control. 
 This study includes analysis of trials reporting adherence to the study diet, showing 
this has no material impact on the outcome, and brings the evidence up to date by 
including more recent trials.  
 Clinicians should inform patients with Type 2 DM there are a number of effective 
dietary approaches for improving glycaemic control, which may include restricting 
carbohydrate to 50-130g per day. 
 
Introduction 
Diabetes affects an estimated 4.5 million people in the UK and 415 million globally, with type 
2 diabetes (T2DM) accounting for approximately 90% of cases.1,2 In the United Kingdom 
Prospective Diabetes Study (UKPDS), each 11mmol/mol (1%) reduction in HbA1c was 
associated with a 21% risk reduction for any end point and 37% for macrovascular 
complications.3 Nutrition therapy interventions have been shown to reduce HbA1c by up to 
22mmol/mol (2.0%) and there is significant current interest in the role of dietary 
carbohydrates for weight control, and in the context of Type 2 DM for the control of 
glycaemia.4,5 However, the ideal amount of dietary carbohydrate remains unclear. Current 
American & European diabetes organisations do not make strong recommendations about 
the quantity of carbohydrate and rather state that monitoring of total carbohydrate is a key 
strategy in achieving glycaemic control, with the focus for dietary change instead targeted at 
weight loss in the overweight.6–8 The average proportion of energy from carbohydrate in the 
UK general population is 47%, and it is estimated a similar amount is consumed in people with 
Type 2 DM.9 Several reviews considering the binary options of low- or high-carbohydrate diets 
have produced mixed results.10–13 Recent meta-analyses of low carbohydrate diets have 
consistently found a small but significant reduction in HbA1c in the pooled effect at 6 months 
that was no longer present at 12 months, supporting the conclusions made in earlier 
reviews.13–15  Another recent review found modest reductions in HbA1c present at 12 
months.16 The review by van Wyk et al10 highlighted the difficulty people find in adhering to 
prescribed diets, showing just an 8g per day difference in the carbohydrate content of diets 
between study arms at the end of the studies. The aim of this review is to evaluate the impact 
of carbohydrate restriction on glycaemic control in adults with Type 2 DM.  
 
Methods 
Data Sources and Searches  
This systematic review and meta-analysis was conducted with reference to the Cochrane 
Handbook for Systematic Reviews of Interventions17 and reported in accordance with the 
PRISMA statement.18 A protocol was published and registered with PROSPERO in advance.19  
The search dates were restricted to 1976 onwards (due to the introduction of HbA1c at this 
time 20) and were up to April 2018. Databases searched included Medline (1976 – April 2018), 
Embase (1980 – April 2018) and CINAHL (1982 – April 2018). Databases of on-going trials, The 
Cochrane Library and DARE, dissertations and theses and other grey literature were also 
searched. Search terms and the search strategy were developed by the research team and 
search results were indecently independently reviewed by PDM & SKR. Summary data were 
sought and data extraction carried out by PDM, verified by SKR, with any conflicts over 
inclusion resolved by discussion.  
 
Study Selection 
Studies were eligible for inclusion if they were randomized controlled trials (RCTs) including 
adults diagnosed with Type 2 DM; had a minimum intervention duration of 8 weeks and 
outcomes reporting at a minimum of 12 weeks; and the intervention restricted the proportion 
or quantity of dietary carbohydrate. Studies using active control diets were included, however 
not if the control diet included carbohydrate restriction in comparison to the intervention 
diet. Included studies also needed to report actual (self-reported or measured) carbohydrate 
intake during or at the end of the intervention and HbA1c as an outcome measure. All 
countries, languages and settings were eligible.  
 
Data Extraction and Quality Assessment 
Data extraction was carried out by PDM, verified by SKR, with any conflicts over inclusion 
resolved by discussion. Data were extracted to a purposely designed spread sheet by PDM 
and checked by SKR. Data items included: study and participant characteristics (including 
duration, setting, ethnicity, age, sex); details of the intervention & control diets (including 
macronutrient composition prescribed, other dietary advice given); outcome data for HbA1c, 
weight, blood pressure (BP) and lipids; and details of retention rates and dietary adherence, 
where available. Risk of bias was assessed according to the Cochrane Handbook for 
Systematic Reviews of Interventions17 at study level and inputted into Review Manager 5.3.21 
 
Data Synthesis and Analysis 
Means and Standard Deviations (or Standard Error) were used to conduct meta-analyses for 
the primary outcomes HbA1c and body weight using a random effects model and to compare 
interventions using weighted mean difference and 95% confidence intervals. Where data for 
people with diabetes was part of a larger cohort including non-diabetes participants, if 
separate data were not reported, authors were contacted to request the relevant values for 
only the participants with Type 2 DM. Additional or missing data were obtained from 4 of the 
5 authors contacted 22–25 and where it they were not available, the study was not included in 
the meta-analysis. Two studies did not report data for body weight and were therefore 
excluded from the meta-analysis.25,26 Comparison of the carbohydrate quantity of 
intervention diets was in absolute grams of carbohydrate, rather than % of total energy, to 
allow for direct and accurate comparison. Where studies reported only % of total energy from 
carbohydrate, a conversion was made using 4kcal per 1g carbohydrate, based on the mean 
reported energy (calorie) intake for each study, or based on an assumed calorie intake of 
2,000kcal if this these data was were not available.27 Included studies reported HbA1c values 
as DCCT-aligned (%)28 rather than the newer IFCC-standardised  concentrations29 and these 
were used in this review without conversion to avoid potential errors. Sub-group analysis 
based on levels of carbohydrate intake were conducted to elicit differences in the key 
outcomes between groups of carbohydrate intake. Level descriptors of carbohydrate intake 
proposed by Feinman and Acurso30 have been widely adopted in the field of carbohydrate 
research and were used to define the sub-groups in this meta-analysis. Only two studies31,32 
met the definition of ‘High’ carbohydrate and therefore this group was collapsed with the 
‘Moderate’ category to form a group named ‘Moderate+’ in this analysis. Heterogeneity in 
the sample of studies was assessed using the I2 statistic and the significance of the associated 
Chi2 value (p<0.05). Heterogeneity within each subgroup was examined as well as the overall 
I2, and a test for heterogeneity between subgroups was also performed. 
Results  
Search Results 
The selection of studies is indicated in Figure 1 according to the PRISMA18 flow diagram. Initial 
database searches yielded 1,402 articles and 72 full-text articles were retrieved before 
eligibility could be established. There were 25 studies that met the inclusion criteria. 
 
Study Characteristics and risk of bias  
Characteristics of the 25 included trials are summarized in Table 1, grouped according to 
dietary intervention using the definitions of levels of carbohydrate prescribed and outlined in 
Table 2. The moderate and high carbohydrate categories were collapsed for the purpose of 
analyses as there were only two studies meeting the definition of high carbohydrate.  
 
The publication period covered 36 years and ranged from 1981 to 2017. Study duration 
ranged from 12 to 208 weeks, with a mean duration of 56 weeks. The majority of studies 
lasted longer than 26 weeks with 7 studies longer than 52 weeks. All except one study in the 
Low Carbohydrate category lasted for 26 weeks or less and, although this study was 104 
weeks duration, it only reported outcomes at 26 weeks.33 Study sample sizes ranged from 
1222 to 41934 and a total of 2,132 participants were included in this review. Of the 25 included 
studies, 10 of the dietary interventions met the definition of ‘moderate carbohydrate’.  
 
Figures 2 and 3 (figure 3 available as supplementary material) show the risk of bias across 
all studies. The principal risk of bias stemmed from either the poor description of the 
randomization sequence and allocation concealment, or because there was no description of 
the pre-study dietary intake of participants (‘Other bias’). This represented more than one 
third of studies included in this review. 
 
Glycaemic Control  
The baseline and post-intervention values of HbA1c, weight, total cholesterol and BP are 
shown in (Tables 3 and 3a – supplementary material). Blood pressure and lipids were not 
routinely included as outcomes or reported in studies included and were not the main focus 
of this review.  
 Significant between-group differences in HbA1c were observed in just 6 of the 25 trials. 35–40 
Some studies reported significant differences at 6 months which are were not maintained at 
12 months and beyond.33,41 Meta-analyses conducted for HbA1c for all studies found no 
overall effect of modifying carbohydrate and demonstrated a high level of heterogeneity 
(WMD -0.09%, 95% CI -0.28%, 0.10%, P = 0.34, I2 80%, P <0.001) (Figure 2). Sub-group analysis 
of studies meeting the definition of ‘very low carbohydrate’ (<50g per day) also found no 
overall effect with very low levels of heterogeneity observed (WMD -0.20%, 95% CI -0.42%, 
0.03%, P = 0.23, I2 25%, P = 0.09). Analysis of the sub group of 5 low carbohydrate diet studies 
(50-130g per day) showed a statistically and clinically significant result in favour of the 
intervention diet (WMD -0.48%, 95% CI -0.74%, -0.23%, P < 0.001, I2 7%, P = 0.37). All studies 
in this sub-group were of 6 months or less duration, or only reported outcomes at 6 months.  
 
Baseline HbA1c amongst the study groups ranged from 43mmol/mol (6.1%) to 87 mmol/mol 
(10.1%), with some studies specifically excluding participants with poorly-controlled blood 
glucose and others adopting the opposite strategy.  
 
Body Weight 
Changes in body weight or Body Mass Index (BMI) were included in the majority of studies, 
however body weight outcomes were not available for two studies which were therefore 
excluded from the meta-analysis.25,26 Two studies37,42 reported a sample with near healthy 
weight and BMI at baseline. Significant between-group differences in body weight were 
observed in just 5 of the 25 included studies, 3 of which were from the sub group of LCHDs. 
There was no overall effect in the meta-analyses for weight for all studies (WMD -0.13kg, 95% 
CI -0.33kg, 0.08kg, P = 0.22, I2 78%, P <0.001) (Figure 3 – supplementary material). A high 
level of heterogeneity was seen in the pooled meta-analysis but not in the low carbohydrate 
sub group. This sub group showed a statistically significant pooled effect in favour of 
restricted carbohydrate (WMD -0.43kg, 95% CI -0.74kg, -0.12kg, P = 0.006, I2 24%, P = 0.26)., 
although the difference is not clinically significant at less than 0.5kg.  
 
Blood Pressure & Blood Lipids 
Of the 25 studies, 11 did not fully report outcomes for BP and in those that did, changes were 
unremarkable and rarely reached statistical significance. Such differences between groups 
were seen only in the paper by Jonsson et al.35 
 
Complete blood lipid outcomes were reported in 17 of the 25 studies. Statistically significant 
differences between groups were seen in just 7 of the studies and most commonly observed 
difference was a greater increase in HDL-Cholesterol in the modified carbohydrate group.  
 
Study Diets, dietary assessment & adherence 
The amount of carbohydrate participants were instructed to consume within the ‘moderate+’ 
group ranged from 138g per day to 293g per day (or 194g if the two ‘high’ carbohydrate 
studies are excluded). Almost half the studies included in this review did not report or record 
the baseline carbohydrate intake of participants. Several trials in the moderate group 
described the interventions as ‘low carbohydrate’ at a prescribed level based on 40% of total 
energy intake. Adherence to study diets was observed more frequently in the moderate+ 
group than in other groups. 
 
13 studies demonstrated relative adherence to the prescribed carbohydrate intake in the 
intervention arm (+/- 10% in g carbohydrate). A further sub-group analysis of the effect on 
the primary outcome using only these studies showed no impact on overall carbohydrate 
restriction (WMD –0.06 95% CI -0.15, 0.02, P = 0.16, I2 88%, P < 0.01) (Figure 4 – 
supplementary material). 
 
A variety of methods for dietary measurement were used by the individual studies, ranging 
from a 24-hour recall, food frequency questionnaires or 7-day weighed food records to 
smartphone apps such as MyFitnessPal. Several studies did not describe how dietary 
assessment was carried-out.31,37,43  
 
Discussion 
This systematic review and meta-analysis of carbohydrate restriction for glycaemic control in 
Type 2 DM has shown no significant overall effect on HbA1c or body weight. Current national 
nutrition guidelines for Type 2 DM reflect this and do not make a specific recommendation 
about the quantity of carbohydrate.6–8   
 
A small and clinically-significant reduction of 5mmol/mol (0.48%) in HbA1c was seen in the 
sub-group of studies using 50-130g of carbohydrate per day. These studies were 6 months or 
less in duration, or only reported outcomes at 6 months, an important limitation to the clinical 
application of this finding.  Earlier reviews found that reductions in HbA1c or weight at 3 or 6 
months are not maintained beyond 12 months.11,13–15 Adherence to the prescribed diets in 
this group was good and may be an important factor in the positive result seen in the meta-
analysis, but if this success cannot be replicated in longer trials, or using even greater 
reductions in carbohydrate, then this is an important finding with implications for future 
research and clinical practice.  
 
Findings in the context of existing evidence 
Eight other meta-analyses published in the last 5 years address a similar research question to 
the current review and their findings are summarized in Table 5. The lack of agreement 
amongst them is due in part to differences in the methodology, such as the inclusion criteria 
or the approach taken in meta-analysis. A review that considered interventions involving 
carbohydrate restriction to 50-130g per day and lasting up to 12 months found similar 
improvements in glycaemic control to the present review.44 Several reviews found that 
carbohydrate restriction is ineffective beyond 12 months.15,45  Snorgaard et al45 found the 
greatest improvements in HbA1c were associated with the greatest reductions in 
carbohydrate, a finding which is not replicated in the present review. Schwinshackl et al46 
suggested that carbohydrate restricted diets are more effective than other dietary 
approaches in lowering HbA1c in people with Type 2 DM over 60 years old. 
 
Strengths & limitations of underlying studies 
A number of methodological limitations are present across many of the studies included in 
this review, including the lack of isocaloric study arms, the varied methods of dietary 
assessment, differences in baseline glycaemic control of study participants and differences in 
study protocols for adjustment of diabetes medication.  
 
Improvements in HbA1c are regularly seen in both groups in included studies and may be 
related to a reduction in energy intake and subsequent weight loss across the entire study 
population. With some exceptions,23,33,34 most studies did not intend to keep the amount of 
dietary energy between study arms equal, and therefore results may have been confounded 
by differential changes in weight as a result of differing energy intakes between study groups. 
Caution should be exercised in interpreting these outcomes in the context of dietary changes, 
especially given the heterogeneity in the methods of dietary measurement employed, and 
their inherent inaccuracy. 
 
Only 13 of the studies included in this review demonstrated overall concordance with the 
prescribed quantity of carbohydrate, and in several cases where there was concordance, the 
quantity of carbohydrate consumed was very similar to the pre-study or baseline intake.47–50 
The differences between the intervention and control diets often amounted to far more than 
a simple difference in the quantity of carbohydrate consumed. The very nature of adjusting 
either the absolute amount or proportion of one nutrient automatically means either the 
proportion or absolute amount of other (macro)nutrients will also be altered. In fact, this was 
sometimes the primary aim of the study.35,50,51 The food-based elements of the study arms 
are also relevant and, going beyond the reductionist approach of the nutrient content, the 
source of those nutrients may also be significant.  One study used an online programme to 
enable lifestyle changes incorporated several elements of behavioural support, such as 
mindful eating, within the intervention arm but not for the control52. Whilst the authors 
attempt to justify this as a ‘minimum dietary control group’ it must be acknowledged that 
participants’ ability to adhere to the diet in this group may have been severely hindered by 
the lack of additional support and therefore it is not merely the difference in composition of 
the diet that is being tested. In fact, there was a significantly higher attrition rate in this 
control group which may be due to this. Participants self-rated the control diet as being 
harder to follow. The results of the present review are consistent with the findings from van 
Wyk et al10, who concluded both low carbohydrate and high carbohydrate groups have 
difficulty in achieving and adhering to the prescribed level of carbohydrate intake, with a 
difference between groups as small as 8g per day. Despite Most trials using used an intention-
to-treat approach to the analysis, however none of the studies included in the present review 
performed additional analysis only on participants adhering to the protocol diet. 
 
A wide range of methods of dietary assessment were used across the studies included in this 
review. Despite almost all trials employing a dietitian to advise participants and administer 
the monitoring of dietary intake, there are inherent inaccuracies in whichever method is 
chosen, and comparison between methods has long been recognized as troublesome.53,54  If 
randomization had left significant differences between study arms with respect to the pre-
study habitual dietary intake, this would have to be acknowledged as a potential risk of bias, 
however many of the included studies failed to measure or report the composition of 
participants’ diets prior to commencement of the trial. 35,37,39,43,51,55,56   
 
Other limitations include the wide range of baseline HbA1c values and adjustment of anti-
hyperglycaemic medication. Participants with poorly-controlled blood glucose were part of 
the exclusion criteria in several studies, however this may not be representative of a typical 
clinical population. Many studies used a protocol to adjust medication according to blood 
glucose during the trial, whilst others excluded patients based on their diabetes medication. 
Investigators either advised participants to undertake a recommended amount of physical 
activity each day or to continue with their usual activities, but the majority did not report or 
adjust for physical activity level in the analysis, which could be a significant limitation.  
 
RCTs of dietary interventions are notoriously challenging with regards to minimising bias, 
although numerous strategies have been recommended.57 Blinding of treatment allocation 
to patients and those delivering the intervention is rarely possible, and the nature of dietary 
interventions involving complex lifestyle and behaviour changes means participants are likely 
to have a strong preference, which may in turn affect adherence and attrition. Subject bias 
and the Hawthorne effect are also likely in dietary intervention trials and may be evident in 
studies in this review, such as Jonasson et al33 in which participants were informed of the diet 
allocation prior to assessment of baseline nutritional intake. Dietary intervention trials are 
complex and it is not usually possible to blind participants, and sometimes the researchers, 
to the treatment allocation due to the nature of the intervention. However, most studies did 
not sufficiently report their efforts to minimize bias in this respect and could have described 
how blinding of outcome assessment and the personnel involved in data handling, for 
instance, might contribute to minimizing bias. Some of the older studies displayed a higher 
risk of bias in some areas which may be related to limits on manuscript length or reporting 
conventions of the period.  
 
Strengths of this review 
This review represents the most recent and comprehensive evaluation of research to 
establish the impact of carbohydrate restriction on glycaemic control in Type 2 DM. Other 
systematic reviews and meta-analyses include database searches up to July 201746 and do not 
include a recent study52 which has been included in the present review. Two reviews also 
looked specifically at low carbohydrate vs. low fat rather than a range of control diets as in 
this review,46,58 and the review by Sainsbury et al15 included studies with participants with 
Type 1 DM. Sub-group analysis of the 13 studies demonstrating relative adherence to the 
intervention diet addresses questions regarding the role of adherence in the primary 
outcome, however this may be confounded by the proportion of studies in the moderate+ 
group which formed part of this sub-group. 
 
The standardisation of definitions relating to the level of carbohydrate intake is an important 
consideration. This review categorized studies according to the proposed levels by Acurso59 
and Feinman et al30, which means some individual studies were re-categorised from their 
stated level of restriction to match these standarised level descriptors. For example, a 
commonly used level to define ‘low carbohydrate’ amongst studies was 40% of total energy 
and, which is now accepted as ‘moderate carbohydrate’. The rationale for selecting this level 
of restriction is rarely explicated, it is likely that this merely represents an intake that is less 
than the habitual intake of western populations.60,61 However, it is much higher than levels 
likely to result in short-term improvements in glycaemic control, as demonstrated in this 
review, and led to participants consuming levels of carbohydrate not dissimilar from their pre-
study consumption.  
 
Limitations of this review  
The inclusion criteria for this review was intended to encompass the breadth of evidence 
regarding levels of carbohydrate in Type 2 DM however the large variation in the duration of 
included trials and in the dietary approaches employed, may also limit the findings. Sub-group 
analysis suggests that including only studies lasting 12 months or more would not have any 
material impact on the overall pooled effect, a finding supported by other reviews that have 
grouped their analyses by study duration.15,45 The exclusion of trials that did not report the 
carbohydrate intake of participants is recognised as a potential source of bias, however this 
resulted in the exclusion of only one RCT62 and most trials were excluded due to either their 
duration or non-reporting of the primary outcome (HbA1c).   
 
The meta-analysis for HbA1c includes a sub-group of trials of moderate carbohydrate in which 
a high level of heterogeneity is observed (I2 82%, p<0.001). A wide range of different dietary 
approaches are employed in this group, which may confound the ability to draw conclusions 
from the pooled effect.  
 
The present review did not undertake a meta-regression to assess the effects of other 
variables on the primary outcome of HbA1c, such as changes in diabetes medication, physical 
activity or weight. Many of the studies did not report on medication changes or physical 
activity, so this remains a potential unobserved confounder. Weight loss is recognised as a 
significant predictor of improvements in glycaemic control in Type 2 DM and the network 
meta-analysis by Schwingschackl et al46 demonstrated that significant relationship between 
reduction in HbA1c and mean differences in weight. However, meta-regression is not always 
appropriate where there are fewer than 10 studies in a sub-group17 as is the case for two of 
the sub-groups included in this meta-analysis. 
 
Conclusion  
This review provides evidence of short term improvements in glycaemic control from a 
restriction in carbohydrate intake to 50-130g per day, however it suggests there is little 
evidence to support recommending a general restriction of carbohydrate intake for all 
patients with Type 2 DM. Controversy in the area of dietary carbohydrate will likely persist, 
with recent publications such as the PURE study calling for dietary guidelines to be 
reconsidered.63 However, data from studies of carbohydrate-restricted diets raises important 
questions over the long-term sustainability of such diets, given the poor overall concordance 
with the prescribed quantity of carbohydrate, even in a trial setting.  As suggested by Van 
Wyk et al10, it is likely there is significant variation in glycaemic response to carbohydrate 
between patients, which may explain the inconclusive nature of trials. Future research should 
consider the acceptability of carbohydrate-restricted diets and how to identify patients who 
will benefit most from being offered this approach. Researchers planning trials in this field 
should consider carefully the added value of further RCTs, given the number of systematic 
reviews already published. In order to add value, any future trials should be long-term 
(greater than 12 months), adopt the prevailing definitions of low carbohydrate and intend to 
keep the caloric content of the diets in study arms equal. Current guidelines should reflect 
the short-term improvements in glycaemic control that diets restricted to 50-130g of 
carbohydrate per day can offer as the evidence-based approach in Type 2 DM.  
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